Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results
- Citation:
- J Clin Oncol vol 24 (18s) abstr. 3509
- Meeting Instance:
- ASCO 2006
- Year:
- 2006
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. Venook D. Niedzwiecki D. Hollis S. Sutherland R. Goldberg S. Alberts A. Benson J. Wade R. Schilsky R. Mayer
- Networks:
- Study
- CALGB-80203
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: